Jenburkt Pharmaceuticals Limited
Promoter holding in Jenburkt Pharmaceuticals Limited was 46.62% in Jun 2026.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 46.62% | 53.38% |
Compared with similar companies
Promoter holding in Jenburkt Pharmaceuticals Limited is lower than 71% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Jenburkt Pharmaceuticals Limited | 46.62% |
| Medicamen Biotech Limited | 40.46% |
| Aarey Drugs & Pharmaceuticals Limited | 42.79% |
| QMS Medical Allied Services Limited | 68.11% |
| Albert David Limited | 62.24% |
| Haleos Labs Limited | 72.11% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Jenburkt Pharmaceuticals Limited's promoter holding?
Promoters held 46.62% of Jenburkt Pharmaceuticals Limited as of 30 Jun 2026, and the public held 53.38%.
Are any promoter shares of Jenburkt Pharmaceuticals Limited pledged?
No promoter shares are recorded as pledged.
How does Jenburkt Pharmaceuticals Limited's promoter holding compare with similar companies?
Promoter holding in Jenburkt Pharmaceuticals Limited is lower than 71% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.